The U.S. Federal Trade Commission announced its first crackdown on deceptive claims in the CBD market Thursday, issuing fines and sanctions to six manufacturers accused of misleading consumers about the health benefits of the cannabis extract.
The FTC, an independent government agency charged with consumer protection, says the six companies made illegal claims about their products’ ability to treat diseases including cancer, high blood pressure and Alzheimer’s disease.
Read MORE
